The C‐terminal fragment of parathyroid hormone‐related peptide promotes bone formation in diabetic mice with low‐turnover osteopaenia
Open Access
- 22 February 2011
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 162 (6), 1424-1438
- https://doi.org/10.1111/j.1476-5381.2010.01155.x
Abstract
Current data suggest that parathyroid hormone (PTH)-related peptide (PTHrP) domains other than the N-terminal PTH-like domain contribute to its role as an endogenous bone anabolic factor. PTHrP-107-139 inhibits bone resorption, a fact which has precluded an unequivocal demonstration of its possible anabolic action in vivo. We thus sought to characterize the osteogenic effects of this peptide using a mouse model of diabetic low-turnover osteopaenia. PTHrP-107-139 was administered to streptozotocin-induced diabetic mice, with or without bone marrow ablation, for 13 days. Osteopaenia was confirmed by dual-energy X-ray absorptiometry and microcomputed tomography analysis. Histological analysis was performed on paraffin-embedded bone tissue sections by haematoxylin/eosin and Masson's staining, and tartrate-resistent acid phosphatase immunohistochemistry. Mouse bone marrow stromal cells and osteoblastic MC3T3-E1 cells were cultured in normal and/or high glucose (HG) medium. Osteogenic and adipogenic markers were assessed by real-time PCR, and PTHrP and the PTH(1) receptor protein expression by Western blot analysis. PTHrP-107-139 reversed the alterations in bone structure and osteoblast function, and also promoted bone healing after marrow ablation without affecting the number of osteoclast-like cells in diabetic mice. This peptide also reversed the high-glucose-induced changes in osteogenic differentiation in both bone marrow stromal cells and the more differentiated MC3T3-E1 cells. These findings demonstrate that PTHrP-107-139 promotes bone formation in diabetic mice. This mouse model and in vitro cell cultures allowed us to identify various anabolic effects of this peptide in this scenario.Keywords
This publication has 56 references indexed in Scilit:
- PTHrP 1-141 and 1-86 Increase In Vitro Bone FormationJournal of Surgical Research, 2010
- The midregion, nuclear localization sequence, and C terminus of PTHrP regulate skeletal development, hematopoiesis, and survival in miceThe FASEB Journal, 2010
- Guide to Receptors and Channels (GRAC), 4th editionBritish Journal of Pharmacology, 2009
- Positive Correlation of PTH-Related Peptide with Glucose in Type 2 DiabetesExperimental Diabetes Research, 2009
- Type 2 diabetic mice demonstrate slender long bones with increased fragility secondary to increased osteoclastogenesisBone, 2009
- Severe growth retardation and early lethality in mice lacking the nuclear localization sequence and C-terminus of PTH-related proteinProceedings of the National Academy of Sciences of the United States of America, 2008
- High d(+)glucose concentration inhibits RANKL-induced osteoclastogenesisBone, 2008
- Guide to Receptors and Channels (GRAC), 3rd editionBritish Journal of Pharmacology, 2008
- Altered Selectivity of Parathyroid Hormone (PTH) and PTH-Related Protein (PTHrP) for Distinct Conformations of the PTH/PTHrP ReceptorMolecular Endocrinology, 2008
- Glucocorticoids Act Directly on Osteoclasts to Increase Their Life Span and Reduce Bone DensityEndocrinology, 2006